Theranostic Nanoparticles for Pancreatic Cancer Treatment-Reference-Cited by-同舟云学术

Theranostic Nanoparticles for Pancreatic Cancer Treatment

Published:2021-02-12 Issue:2 Volume:21 Page:203-214
ISSN:1871-5303
Container-title:Endocrine, Metabolic & Immune Disorders - Drug Targets
language:en
Short-container-title:EMIDDT

Author:

Jaidev Leela R.¹^ORCID,Chede Laxmi S.¹,Kandikattu Hemanth K.²

Affiliation:

1. College of Pharmacy, University of Iowa, 52246, Iowa,United States

2. Department of Medicine, Tulane Eosinophilic Disorders Centre (TEDC), Section of Pulmonary Diseases, Tulane University School of Medicine, New Orleans, LA 70112,United States

Abstract

Pancreatic cancer is one of the low vascular permeable tumors with a high mortality rate. The five-year survival period is ~5%. The field of drug delivery is at its pace in developing unique drug delivery carriers to treat high mortality rate cancers such as pancreatic cancer. Theranostic nanoparticles are the new novel delivery carriers where the carrier is loaded with both diagnostic and therapeutic agents. The present review discusses various therapeutic and theranostic nanocarriers for pancreatic cancer.

Publisher

Bentham Science Publishers Ltd.

Subject

Immunology and Allergy,Endocrinology, Diabetes and Metabolism

Reference82 articles.

1. Street W.; Cancer Facts 2019

2. Odze R.D.; Goldblum J.R.; Surgical pathology of the GI tract, liver, biliary tract, and pancreas 2009

3. Delpu Y.; Hanoun N.; Lulka H.; Sicard F.; Selves J.; Buscail L.; Torrisani J.; Cordelier P.; Genetic and epigenetic alterations in pancreatic carcinogenesis. Curr Genomics 2011,12(1),15-24

4. Lowy A.M.; Leach S.D.; Philip P.; Pancreatic cancer 2008

5. Bamford S.; Dawson E.; Forbes S.; Clements J.; Pettett R.; Dogan A.; Flanagan A.; Teague J.; Futreal P.A.; Stratton M.R.; Wooster R.; The COSMIC (Catalogue of somatic mutations in cancer) database and website. Br J Cancer 2004,91(2),355-358

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Theranostics: Pharmaceutical View;Pharmaceutical Science;2024-08-21

2. Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA;Cell Biochemistry and Biophysics;2024-07-10

3. Responsive Nanomaterial Delivery Systems for Pancreatic Cancer Management;Advanced Therapeutics;2023-12-15

4. Infection with COVID-19 promotes the progression of pancreatic cancer through the PI3K-AKT signaling pathway;Discover Oncology;2023-12-08

5. Small-scale particles showing large-scale impact in pancreatic cancer;Nanomedicine;2023-10-31